Document Detail


Alterations in PMS2, MSH2 and MLH1 expression in human prostate cancer.
MedLine Citation:
PMID:  12684669     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
DNA mismatch repair (MMR) is involved in the post-replication correction of errors due to misincorporated nucleotides or DNA slippage during DNA synthesis. We previously reported the reduction or loss of MMR protein expression in human prostate cancer cell lines and some primary tumors. In the present report, we further demonstrate the involvement of defects of MMR in the pathogenesis of prostate cancer. Immunohistochemical analysis of 39 formalin-fixed, paraffin-embedded human prostate tumors, showed reduction or absence of MMR protein expression (MLH1, MSH2, PMS2) in the epithelium of prostate tumor foci compared to normal adjacent prostate tissue. The reduction or absence of the PMS2 and MSH2 (but not MLH1) protein was correlated to the differentiation of the tumor. Poorly differentiated tumors showed greater loss of these two proteins than the well differentiated tumors (P<0.05). We previously reported that microsatellite instability was detectable by a beta-galactosidase restoration mutation assay in the prostate cancer cell lines DU145, PC3, LNCaP, p67SV40T, M2182, and M12. In this study, we detected the insertion or deletion of one nucleotide in the mononucleotide repeats located within the coding regions of BAX gene in DU145, and TGFbetaRII in M12 cells. In addition, we used an in vitro model of defective MMR to demonstrate that microsatellite instability can be induced in an otherwise stable cancer cell line by transfection with a dominant negative fragment of PMS2. These results suggest that defects in MMR may result in MSI in the secondary genes in prostate cancer. From these results, we conclude that loss of MMR function can produce MSI and target some secondary genes containing microsatellites in their coding regions. These series of events may play important roles in the development of human prostate cancer.
Authors:
Yian Chen; Jiansong Wang; Mostafa M Fraig; Kelly Henderson; Nabil K Bissada; Dennis K Watson; Clifford W Schweinfest
Related Documents :
7518349 - Detection of discrete androgen receptor epitopes in prostate cancer by immunostaining: ...
18765529 - Overexpression of the zinc uptake transporter hzip1 inhibits nuclear factor-kappab and ...
15624309 - Hypoxia in the androgen-dependent shionogi model for prostate cancer at three stages.
17707459 - Correlative evidence that prostate cancer cell-derived caveolin-1 mediates angiogenesis.
2448499 - Heterogeneous subpopulations of human prostatic adenocarcinoma cells: potential usefuln...
8170839 - Characterization of peripheral benzodiazepine receptors in rat prostatic adenocarcinoma.
8890959 - A general overview of the process of carcinogenesis.
21053299 - Viable tumor in postchemoradiation neck dissection specimens as an indicator of poor ou...
16106159 - Nipple-areola complex preservation: predictive factors of neoplastic nipple-areola comp...
Publication Detail:
Type:  Journal Article; Research Support, U.S. Gov't, Non-P.H.S.    
Journal Detail:
Title:  International journal of oncology     Volume:  22     ISSN:  1019-6439     ISO Abbreviation:  Int. J. Oncol.     Publication Date:  2003 May 
Date Detail:
Created Date:  2003-04-09     Completed Date:  2003-08-11     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  9306042     Medline TA:  Int J Oncol     Country:  Greece    
Other Details:
Languages:  eng     Pagination:  1033-43     Citation Subset:  IM    
Affiliation:
Laboratory of Cancer Genomics, Hollings Cancer Center, Medical University of South Carolina, Charleston, SC 29425, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adaptor Proteins, Signal Transducing
Adenosine Triphosphatases / genetics*,  metabolism
Base Pair Mismatch / genetics*
Base Sequence
Carrier Proteins
DNA Primers
DNA Repair / genetics*
DNA Repair Enzymes*
DNA-Binding Proteins / genetics*,  metabolism
Gene Expression Regulation, Neoplastic*
Humans
Immunohistochemistry
Male
Microsatellite Repeats
MutS Homolog 2 Protein
Mutation*
Neoplasm Proteins / genetics*
Nuclear Proteins
Polymerase Chain Reaction
Prostatic Neoplasms / genetics*,  pathology
Proto-Oncogene Proteins / genetics*,  metabolism
Recombinant Proteins / metabolism
Transfection
Tumor Cells, Cultured
Chemical
Reg. No./Substance:
0/Adaptor Proteins, Signal Transducing; 0/Carrier Proteins; 0/DNA Primers; 0/DNA-Binding Proteins; 0/MLH1 protein, human; 0/Neoplasm Proteins; 0/Nuclear Proteins; 0/Proto-Oncogene Proteins; 0/Recombinant Proteins; EC 3.6.1.-/Adenosine Triphosphatases; EC 3.6.1.-/PMS2 protein, human; EC 3.6.1.3/MSH2 protein, human; EC 3.6.1.3/MutS Homolog 2 Protein; EC 6.5.1.-/DNA Repair Enzymes

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Promoter hypermethylation of cyclooxygenase-2 in gastric carcinoma.
Next Document:  Identification of MG-160, a FGF binding medial Golgi sialoglycoprotein, in brain tumors: an index of...